Does an endogenous methylpyridinium analogue cause Parkinson's disease?

scientific article published on 01 September 1985

Does an endogenous methylpyridinium analogue cause Parkinson's disease? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.2042-7158.1985.TB05116.X
P698PubMed publication ID2867199

P2093author name stringC D Marsden
B Testa
P Jenner
R Naylor
B Costall
P433issue9
P921main subjectParkinson's diseaseQ11085
P304page(s)679-680
P577publication date1985-09-01
P1433published inJournal of Pharmacy and PharmacologyQ10532762
P1476titleDoes an endogenous methylpyridinium analogue cause Parkinson's disease?
P478volume37

Reverse relations

cites work (P2860)
Q41838970Acute Effects of 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine in a Model of Rat Designated a Poor Metabolizer of Debrisoquine
Q41334106Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.
Q39677855Antioxidant therapy in Parkinson's disease
Q69745291Ecogenetics of Parkinson's disease: prevalence and environmental aspects in rural areas
Q43818793Effect of acute administration of 1,2,3,4-tetrahydroisoquinoline on the levels of glutathione and reactive oxygen species, and on the enzymatic activity of gamma-glutamyl transpeptidase in dopaminergic structures of rat brain
Q33890767Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats
Q48545863Indole-N-methylated β-carbolinium ions as potential brain-bioactivated neurotoxins
Q48183426MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation
Q33917363Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine
Q73466546Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain
Q33588811Oxidative polymorphism of debrisoquine in Parkinson's disease
Q48389819Studies on the interaction between 1,2,3,4-tetrahydro-beta-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease.
Q48111609Tetrahydroisoquinoline lacks dopaminergic nigrostriatal neurotoxicity in mice

Search more.